Pfizer and BioNTech submit data they say show shots are safe in 5- to 11-year-olds.



The companies said that they would submit a formal request to regulators to allow a pediatric dose of their vaccine to be administered in the United States in the coming weeks. By Sharon LaFraniere and Shashank Bengali from NYT U.S…. Read more.

Leave a Reply